To evaluate the importance of the FL-SMN/SMNΔ7 mRNA ratio as a SMA biomarker, we carried out RT-qPCR based quantification of FL-SMN and SMNΔ7 mRNA levels in a small group of type II and III SMA patients. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.